메뉴 건너뛰기




Volumn 4, Issue 2, 2009, Pages 146-160

Peptides and peptide mimics as modulators of apoptotic pathways

Author keywords

Apoptosis; Caspases; Inhibitors; Peptides; Peptidomimetics

Indexed keywords

3 [2 [(2 TERT BUTYLPHENYLAMINOOXALYL)AMINO]PROPIONYLAMINO] 4 OXO 5 (2,3,5,6 TETRAFLUOROPHENOXY)PENTANOIC ACID; 4 [4 (4' CHLORO 2 BIPHENYLYLMETHYL) 1 PIPERAZINYL] N [4 [3 DIMETHYLAMINO 1 (PHENYLTHIOMETHYL)PROPYLAMINO] 3 NITROBENZENESULFONYL]BENZAMIDE; APOPTOSIS INHIBITOR; APOPTOTIC PROTEASE ACTIVATING FACTOR 1; BH3 DERIVED PROTEIN; BORTEZOMIB; CARFILZOMIB; CASPASE; CASPASE INHIBITOR; CD40 LIGAND MONOCLONAL ANTIBODY; DUAL SPECIFICITY PHOSPHATASE 2; GOSSYPOL; HUMANIN; NUTLIN 1; OBATOCLAX; PEPTIDE; PEPTIDOMIMETIC AGENT; PEPTOID; PEPTOID 1; PR 171; PROTEASOME INHIBITOR; PROTEIN BCL 2; PROTEIN DERIVATIVE; R8 BH3 PEPTIDE; SALINOSPORAMIDE A; SURVIVIN; TERPHENYL DERIVATIVE; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; UNCLASSIFIED DRUG; UNINDEXED DRUG; X LINKED INHIBITOR OF APOPTOSIS;

EID: 60849092261     PISSN: 18607179     EISSN: 18607187     Source Type: Journal    
DOI: 10.1002/cmdc.200800246     Document Type: Review
Times cited : (5)

References (204)
  • 18
    • 60849120732 scopus 로고    scopus 로고
    • accessed October 30, 2008
    • Amgen: http://wwwext.amgen.com/science/pipe.jsp (accessed October 30, 2008).
  • 19
    • 60849109926 scopus 로고    scopus 로고
    • accessed October 30, 2008
    • Genentech : http://www.gene.com/gene/pipeline/status/oncology/apo2l/ (accessed October 30, 2008).
  • 58
    • 60849123895 scopus 로고    scopus 로고
    • H.E. Blackwell, R. H. Grubbs, Angew. Chem. 1998, 110, 3469-3472; Angew. Chem. Int. Ed. 1998, 37, 3281-3284.
    • H.E. Blackwell, R. H. Grubbs, Angew. Chem. 1998, 110, 3469-3472; Angew. Chem. Int. Ed. 1998, 37, 3281-3284.
  • 61
    • 60849115531 scopus 로고    scopus 로고
    • J. W. Chin, A. Schepartz, Angew. Chem. 2001, 113, 3922-3925; Angew. Chem. Int. Ed. 2001, 40, 3806-3809.
    • J. W. Chin, A. Schepartz, Angew. Chem. 2001, 113, 3922-3925; Angew. Chem. Int. Ed. 2001, 40, 3806-3809.
  • 84
    • 60849091019 scopus 로고    scopus 로고
    • accessed October 30, 2008
    • Ascenta Therapeutics: http://www.ascenta.com/Ascenta/ascenta-development- pipeline/ascenta-development-pipeline.html (accessed October 30, 2008).
    • Ascenta Therapeutics
  • 85
    • 60849108893 scopus 로고    scopus 로고
    • accessed October 30, 2008
    • Gemin X Pharmaceuticals: http://www.geminx.com/en/research/gx15070.php (accessed October 30, 2008).
    • Gemin X Pharmaceuticals
  • 104
    • 0036205587 scopus 로고    scopus 로고
    • Y. Shi, Mol. Cell 2002, 9, 459-470.
    • (2002) Mol. Cell , vol.9 , pp. 459-470
    • Shi, Y.1
  • 107
    • 0034616946 scopus 로고    scopus 로고
    • D. R. Green, Cell 2000, 102, 1-4.
    • (2000) Cell , vol.102 , pp. 1-4
    • Green, D.R.1
  • 157
    • 60849118919 scopus 로고    scopus 로고
    • U.S. NIH: http://clinicaltrials.gov/ct2/show/NCT00708006?rcv-s= 06%2F30%2F2008&rank=23 (accessed October 30, 2008).
    • U.S. NIH: http://clinicaltrials.gov/ct2/show/NCT00708006?rcv-s= 06%2F30%2F2008&rank=23 (accessed October 30, 2008).
  • 198
  • 201
    • 60849124792 scopus 로고    scopus 로고
    • R. H. Feling, G. O. Buchanan, T. J. Mincer, C. A. Kauffman, P. R. Jensen, W. Fenical, Angew. Chem. 2003, 115, 369-371; Angew. Chem. Int. Ed. 2003, 42, 355-357.
    • R. H. Feling, G. O. Buchanan, T. J. Mincer, C. A. Kauffman, P. R. Jensen, W. Fenical, Angew. Chem. 2003, 115, 369-371; Angew. Chem. Int. Ed. 2003, 42, 355-357.


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.